4Filed Aug 27, 8:00 PM ET

Fulgent Genetics (FLGT) CSO Gao Hanlin Sells 939 Shares

$FLGT · Fulgent Genetics, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Fulgent Genetics (FLGT) CSO Gao Hanlin Sells 939 Shares

What Happened Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), sold 939 shares in an open-market transaction on 2026-08-27 at a weighted-average price of $19.91, generating proceeds of about $18,691. The filing indicates the sale was to satisfy tax-withholding obligations tied to restricted stock units granted on February 26, 2024.

Key Details

  • Transaction date: 2026-08-27; Form 4 filed: 2026-08-28 (appears timely).
  • Sale type/code: Open-market sale (S).
  • Shares sold: 939; weighted-average price: $19.91; total proceeds ≈ $18,691.
  • Price range: transactions occurred at $19.83 to $20.00; reported price is the weighted average (footnote F2).
  • Reason: Shares were sold to satisfy tax withholding on RSU vesting from the Feb 26, 2024 grant (footnote F1).
  • Shares owned after the transaction: not provided in the supplied filing details.

Context This sale was executed as tax-withholding for vested RSUs (a common, non-speculative reason insiders sell). Such covers-for-taxes sales typically reflect administrative needs rather than a directional view on the stock.